Nov 28, 2006, 09.32 AM IST
Dolphin Medical Services counter has, of late, been active on expectation of major corporate developments. The stock has gained 48% in the last one month and the fortnightly average volume on the BSE is 6.17 lakh shares.
The company has recently entered into an agreement with a nanotechnology company Biomix Network - an Indian outfit of a German company with operational base in Mumbai. Biomix, which has a range of products in the diagnostic, pharmaceuticals and healthcare sectors, is planning to take roughly around 5% stake in Dolphin, Mr S. Rao, Director, Dolphin, confirmed to Business Line.
Dolphin has the sole marketing and distribution rights for Biomix products in the country. Biomix also agreed to license its diagnostics and clinical trial software and activities to Dolphin.
Contd on page 2.......
Dolphin Medical stock price
On December 04, 2013, Dolphin Medical Services closed at Rs 1.13, up Rs 0.05, or 4.63 percent. The 52-week high of the share was Rs 2.16 and the 52-week low was Rs 0.60.
The latest book value of the company is Rs 9.43 per share. At current value, the price-to-book value of the company was 0.12.
Action in Dolphin Medical Services
Video of the day
Dec 4 2013, 16:28
- in Business
Dec 4 2013, 11:08
- in FII View
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.